Cancer Care
CorriXR Launches Bold Collaboration to Create First Inhaled CRISPR Therapy for Lung Cancer
December 5, 2025CorriXR Therapeutics, ChristianaCare’s first commercial biotherapeutics spinout, has launched a major collaboration with InhaTarget Therapeutics and Merxin Ltd to develop an inhaled genetic therapy for lung cancer. The goal is to deliver a CRISPR-based treatment straight to tumors in the lungs to improve effectiveness and cut harmful side effects. A New Way to Treat Lung […] Read more